• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday

    7/22/22 5:04:48 AM ET
    $A
    $AACG
    $ADIL
    $ADMP
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Other Consumer Services
    Real Estate
    Get the next $A alert in real time by email

     

    Gainers

    • Virax Biolabs Group Limited (NASDAQ:VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) gained 110.4% to close at $1.93 after the company issued corporate update and financial guidance. The company announced the reduction of its issued, authorized and conditional share capital from CHF 1.00 to CHF 0.01 and provided corporate updates.
    • 1Life Healthcare, Inc. (NASDAQ:ONEM) gained 69.5% to close at $17.25 after Amazon announced it will acquire the company for $18 per share in an all-cash transaction valued at approximately $3.9 billion.
    • Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) shares jumped 56.5% to close at $4.07 after the company said it expects Q2 sales of $72 – $73 million, exceeding the prior guidance range of $66 – $69 million and the consensus of $67.61 million.
    • Tuesday Morning Corporation (NASDAQ:TUEM) rose 42.8% to close at $0.2838 after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for customized location intelligence solutions.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) climbed 36.5% to close at $5.72.
    • Vertical Aerospace Ltd. (NASDAQ:EVTL) gained 34.3% to close at $8.07. Strength was possibly due to continued momentum after the company announced an order for its VX4 aircrafts last week. The company also announced a partnership to explore new variants for the VX4.
    • Skylight Health Group Inc. (NASDAQ:SLHG) rose 26.5% to close at $0.6450.
    • Entera Bio Ltd. (NASDAQ:ENTX) gained 25.2% to settle at $1.89.
    • Pintec Technology Holdings Limited (NASDAQ:PT) gained 25.1% to close at $1.11.
    • MoonLake Immunotherapeutics (NASDAQ:MLTX) gained 25% to close at $6.91 after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and a $28 price target.
    • Phunware, Inc. (NASDAQ:PHUN) jumped 24.8% to close at $1.76.
    • Kaltura, Inc. (NASDAQ:KLTR) gained 23.7% to settle at $2.56.
    • Altice USA, Inc. (NASDAQ:ATUS) gained 22.3% to settle at $11.23 following a report suggesting the company is said to weigh a Suddenlink sale for up to $20 billion.
    • Belite Bio, Inc (NASDAQ:BLTE) jumped 22.1% to close at $41.51.
    • LightPath Technologies, Inc. (NASDAQ:LPTH) surged 21.5% to close at $1.75.
    • SkyWater Technology, Inc. (NASDAQ:SKYT) gained 21.3% to close at $13.16.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 20.7% to close at $1.00. Evofem partnered with A360 media to support Phexxi prescription growth.
    • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) gained 20.6% to close at $5.68 after the FDA granted Fast Track designation to OP-1250, the company's oral complete estrogen receptor antagonist and selective ER degrader.
    • Datasea Inc. (NASDAQ:DTSS) rose 20% to close at $2.22. Datasea’s subsidiary Guohao Century (Beijing) Technology recently inked a purchase agreement with Hangzhou Runsheng Network Technology Ltd, a leading marketing service provider, for a consideration of $22.3 million (RMB 150 million).
    • Acutus Medical, Inc. (NASDAQ:AFIB) gained 18.7% to close at $1.65. Acutus Medical appointed David Roman as President and CEO. The company also said it sees preliminary Q2 sales of $4 million to $4.1 million.
    • Nymox Pharmaceutical Corporation (NASDAQ:NYMX) surged 18.1% to close at $0.36.
    • Standard Lithium Ltd. (NYSE:SLI) jumped 18% to settle at $5.44.
    • ATA Creativity Global (NASDAQ:AACG) gained 17.4% to settle at $1.62.
    • Digital Media Solutions, Inc. (NYSE:DMS) jumped 17.3% to close at $1.49.
    • Boxed, Inc. (NYSE:BOXD) gained 16.8% to close at $2.30.
    • COMSovereign Holding Corp. (NASDAQ:COMS) gained 16.5% to close at $0.1658.
    • Velo3D, Inc. (NYSE:VLD) gained 15.8% to close at $3.38.
    • Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) rose 15.5% to close at $1.42.
    • Expion360 Inc. (NASDAQ:XPON) gained 15.5% to settle at $3.36.
    • Oyster Point Pharma, Inc. (NASDAQ:OYST) jumped 15.3% to settle at $6.39.
    • Repligen Corporation (NASDAQ:RGEN) gained 15.3% to close at $203.64. UBS initiated coverage on Repligen with a Buy rating and announced a price target of $213.
    • Cano Health, Inc. (NYSE:CANO) rose 13.8% to settle at $6.50.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) rose 13.3% to close at $51.63 after the company issued Q4 sales guidance above estimates.
    • CareMax, Inc. (NASDAQ:CMAX) gained 12.1% to settle at $6.48.
    • PARTS iD, Inc. (NYSE:ID) jumped 11.1% to close at $1.20. EF Hutton initiated coverage on PARTS iD with a Buy rating and announced a price target of $3.
    • Tesla, Inc. (NASDAQ:TSLA) rose 9.8% to close at $815.12. Tesla posted better-than-expected earnings for its second quarter, while sales missed estimates. Second-quarter deliveries were 254,695, up 27% year-over-year.
    • Danaher Corporation (NYSE:DHR) gained 9.1% to close at $279.23 after the company reported better-than-expected Q2 EPS and sales results.
    • Nokia Oyj (NYSE:NOK) rose 8.9% to close at $5.12 after reporting upbeat Q2 profit.
    • Bio-Rad Laboratories, Inc. (NYSE:BIO) gained 7.7% to settle at $534.41. Bio-Rad Laboratories is expected to report its financial results for the second quarter on Thursday, July 28, 2022.
    • Agilent Technologies, Inc. (NYSE:A) surged 6.1% to settle at $127.19. UBS recently initiated coverage on Agilent Technologies with a Buy rating and announced a price target of $139.
    • Philip Morris International Inc. (NYSE:PM) gained 4.2% to close at $93.59 after the company reported better-than-expected Q2 EPS and sales results and issued FY22 EPS guidance above estimates.

     

    • Losers

    • LumiraDx Limited (NASDAQ:LMDX) shares tumbled 37% to close at $1.33 after the company reported pricing of public offering of common shares and concurrent private placement.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) fell 31.7% to close at $0.41. NLS Pharmaceutics announced positive opinion from European Regulators to grant orphan drug designation for Mazindol ER in idiopathic hypersomnia.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) dropped 26.5% to close at $3.41.
    • ProPhase Labs, Inc. (NASDAQ:PRPH) dipped 24.7% to close at $10.33. The company earlier announced a license agreement for its Linebacker portfolio, under which PBIO has obtained exclusive rights worldwide to develop and commercialize LB-1 and LB-2 for the treatment of multiple diseases.
    • Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) declined 16.7% to close at $0.4015.
    • 36Kr Holdings Inc. (NASDAQ:KRKR) dropped 16% to close at $0.9320.
    • Insteel Industries, Inc. (NASDAQ:IIIN) fell 15.6% to close at $2.98 after the company posted weaker-than-expected Q3 results.
    • Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) fell 14.9% to close at $0.8336. Adial Pharmaceuticals shares dipped around 47% on Wednesday after the company announced topline results for its Onward Phase 3 trial for AD04 in patients with Alcohol Use Disorder.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) fell 13.7% to close at $5.35. Pagaya Technologies shares jumped around 130% on Wednesday on continued volatility after the company completed its SPAC merger agreement last month.
    • Otonomy, Inc. (NASDAQ:OTIC) fell 12.1% to settle at $1.9350.
    • Vascular Biogenics Ltd. (NASDAQ:VBLT) dipped 11.5% to close at $0.3761 after Chardan Capital downgraded the stock from Buy to Neutral.
    • Sonder Holdings Inc. (NASDAQ:SOND) dropped 11.4% to settle at $1.01.
    • Carnival Corporation (NYSE:CCL) fell 11.2% to close at $9.85 after the company priced its 102 million share offering at $9.95 per share.
    • W&T Offshore, Inc. (NYSE:WTI) dropped 10.6% to close at $3.98.
    • United Airlines Holdings, Inc. (NASDAQ:UAL) shares fell 10.2% to settle at $100.00 as the company posted weaker-than-expected earnings for its second quarter on Wednesday.
    • Richardson Electronics, Ltd. (NASDAQ:RELL) dropped 9.8% to close at $15.24 following Q4 results.
    • Applied Blockchain, Inc. (NASDAQ:APLD) fell 9.6% to close at $2.25 after gaining over 17% on Wednesday.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) dipped 9.2% to close at $2.66.
    • Discover Financial Services (NYSE:DFS) dipped 8.9% to close at $100.00 following Q2 results.
    • Evogene Ltd. (NASDAQ:EVGN) dropped 8.8% to close at $0.93.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) fell 8.6% to settle at $32.81 after the company announced a proposed $200 million public offering of common stock. Also, the company announced a collaboration with Vertex to discover and develop an in vivo editing program for liver disease.
    • Stronghold Digital Mining, Inc. (NASDAQ:SDIG) fell 7.2% to close at $2.98 following a 50% surge on Wednesday.

     

    Get the next $A alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $A
    $AACG
    $ADIL
    $ADMP

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Vertical Aerospace Ltd.
    $EVTL
    2/23/2026Mkt Perform → Underperform
    Raymond James
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    Olema Pharmaceuticals Inc.
    $OLMA
    2/11/2026$48.00Buy
    Stifel
    Nokia Corporation Sponsored
    $NOK
    2/9/2026$8.00Overweight
    Morgan Stanley
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    LightPath Technologies Inc.
    $LPTH
    1/29/2026$15.00Buy
    Canaccord Genuity
    Agilent Technologies Inc.
    $A
    1/20/2026$180.00Buy
    HSBC Securities
    More analyst ratings

    $A
    $AACG
    $ADIL
    $ADMP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Bylund James was granted 125 shares and covered exercise/tax liability with 62 shares, increasing direct ownership by 0.36% to 17,672 units (SEC Form 4)

    4 - REPLIGEN CORP (0000730272) (Issuer)

    3/5/26 1:28:48 PM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Senior VP, R&D Kuriyel Ralf was granted 125 shares and covered exercise/tax liability with 42 shares, increasing direct ownership by 0.56% to 14,778 units (SEC Form 4)

    4 - REPLIGEN CORP (0000730272) (Issuer)

    3/5/26 1:25:03 PM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director North Run Strategic Opportunities Fund I, Lp converted options into 740,000 shares and sold $8,180,640 worth of shares (674,995 units at $12.12) (SEC Form 4)

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    3/4/26 8:00:18 PM ET
    $LPTH
    Semiconductors
    Technology

    $A
    $AACG
    $ADIL
    $ADMP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TYRVAYA issued to OYSTER POINT PHARMA INC

    Submission status for OYSTER POINT PHARMA INC's drug TYRVAYA (ORIG-1) with active ingredient VARENICLINE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 213978, Application Classification: Type 3 - New Dosage Form

    10/19/21 7:27:01 PM ET
    $OYST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZIMHI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug ZIMHI (ORIG-1) with active ingredient NALOXONE HYDROCHLORIDE has changed to 'Approval' on 10/15/2021. Application Category: NDA, Application Number: 212854, Application Classification: Type 5 - New Formulation or New Manufacturer

    10/18/21 11:55:40 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SYMJEPI issued to ADAMIS PHARMS CORP

    Submission status for ADAMIS PHARMS CORP's drug SYMJEPI (SUPPL-12) with active ingredient EPINEPHRINE has changed to 'Approval' on 06/29/2021. Application Category: NDA, Application Number: 207534, Application Classification: Labeling

    6/30/21 5:11:48 AM ET
    $ADMP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $A
    $AACG
    $ADIL
    $ADMP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rubin Steven D bought $7,450 worth of Ordinary Shares (5,000 units at $1.49), increasing direct ownership by 50% to 15,000 units (SEC Form 4)

    4 - Entera Bio Ltd. (0001638097) (Issuer)

    2/17/26 8:30:51 AM ET
    $ENTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Taitel Haya bought $11,100 worth of Ordinary Shares (7,500 units at $1.48), increasing direct ownership by 8% to 98,479 units (SEC Form 4)

    4 - Entera Bio Ltd. (0001638097) (Issuer)

    2/11/26 8:47:27 AM ET
    $ENTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Germano Geno J bought $29,800 worth of Ordinary Shares (20,000 units at $1.49) (SEC Form 4)

    4 - Entera Bio Ltd. (0001638097) (Issuer)

    2/11/26 8:45:55 AM ET
    $ENTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $A
    $AACG
    $ADIL
    $ADMP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on Tesla with a new price target

    BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00

    3/4/26 8:40:18 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Vertical Aerospace Group downgraded by Raymond James

    Raymond James downgraded Vertical Aerospace Group from Mkt Perform to Underperform

    2/23/26 8:34:02 AM ET
    $EVTL
    Aerospace
    Industrials

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $A
    $AACG
    $ADIL
    $ADMP
    SEC Filings

    View All

    SEC Form IRANNOTICE filed by Nokia Corporation Sponsored

    IRANNOTICE - NOKIA CORP (0000924613) (Filer)

    3/5/26 1:03:54 PM ET
    $NOK
    Radio And Television Broadcasting And Communications Equipment
    Technology

    SEC Form 20-F filed by Nokia Corporation Sponsored

    20-F - NOKIA CORP (0000924613) (Filer)

    3/5/26 10:19:13 AM ET
    $NOK
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Philip Morris International Inc. (0001413329) (Filer)

    3/5/26 7:03:07 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $A
    $AACG
    $ADIL
    $ADMP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    United Airlines to Present at the J.P. Morgan 2026 Industrials Conference

    CHICAGO, March 5, 2026 /PRNewswire/ -- United will present at the J.P. Morgan 2026 Industrials Conference on Tuesday, March 17, beginning at 1:00 p.m. EST. On the webcast Scott Kirby, Chief Executive Officer, and Mike Leskinen, Chief Financial Officer, will make remarks on current trends affecting our business.The live webcast will be available on the investor relations section of United's website at ir.united.com. The company will archive the audio webcast on the website within 24 hours of the presentation.About UnitedAt United, Good Leads The Way. With U.S. hubs in Chicago, Denver, Houston, Los Angeles, New York/Newark, San Francisco and Washington, D.C., United operates the most comprehen

    3/5/26 10:00:00 AM ET
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    Repligen Corporation to Present at Upcoming March Conferences

    WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences. The Leerink Global Healthcare Conference, being held March 8 – 11 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 11:20 a.m. ET on Tuesday, March 10, 2026.The Barclays 28th Annual Global Healthcare Conference, being held March 10 – 12 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 10:30 a.m. ET on Wednesday, March 11, 2026.The 2026 KeyBanc Virtual

    3/5/26 7:30:00 AM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

    Conference call and webcast: today, March 05, 2026, 9:00 AM ETREHOVOT, Israel, March 5, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules for the pharmaceutical and agricultural industries, today announced its financial results for the fourth quarter and full year ended December 31, 2025.    Mr. Ofer Haviv, President & CEO of Evogene, stated: "During 2025, we executed a clear and decisive strategic shift. After a comprehensive review of our technology assets, target markets, and capital allocation priorities, we sharpened our focus to drive sustainable long-term value by co

    3/5/26 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    $A
    $AACG
    $ADIL
    $ADMP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    SEC Form SC 13G filed by Olema Pharmaceuticals Inc.

    SC 13G - Olema Pharmaceuticals, Inc. (0001750284) (Subject)

    12/11/24 4:30:15 PM ET
    $OLMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $A
    $AACG
    $ADIL
    $ADMP
    Financials

    Live finance-specific insights

    View All

    Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

    Conference call and webcast: today, March 05, 2026, 9:00 AM ETREHOVOT, Israel, March 5, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative AI design of small molecules for the pharmaceutical and agricultural industries, today announced its financial results for the fourth quarter and full year ended December 31, 2025.    Mr. Ofer Haviv, President & CEO of Evogene, stated: "During 2025, we executed a clear and decisive strategic shift. After a comprehensive review of our technology assets, target markets, and capital allocation priorities, we sharpened our focus to drive sustainable long-term value by co

    3/5/26 7:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

    Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is March 19, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily

    3/5/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    W&T Offshore Reschedules Timing of Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    HOUSTON, March 04, 2026 (GLOBE NEWSWIRE) -- W&T Offshore, Inc. (NYSE:WTI) (the "Company") today announced that it is rescheduling the release of the Company's fourth quarter and full year 2025 earnings release and subsequent conference call, which had been scheduled for Thursday, March 5, 2026, after the close of trading on the NYSE and Friday, March 6, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern Time), respectively. The earnings release is now scheduled to be released Monday, March 16, 2026, after the close of trading on the NYSE. W&T will then hold its year-end 2025 conference call on Tuesday, March 17, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). Interested parti

    3/4/26 5:15:00 PM ET
    $WTI
    Oil & Gas Production
    Energy

    $A
    $AACG
    $ADIL
    $ADMP
    Leadership Updates

    Live Leadership Updates

    View All

    Sharon AI Appoints Mr. Benjamin Adams to Board of Directors

    SharonAI Holdings Inc. ("Sharon AI"), a leading Australian neocloud (NASDAQ:SHAZ), announced on February 24, 2026, that highly experienced global technology executive, Mr. Benjamin Adams, joined the Sharon AI Holdings Inc. board of directors on February 22, 2026. Mr. Adams is a global business and technology leader with deep and broad expertise across financial, technology and regulatory law, mergers & acquisitions, corporate securities reporting, intellectual property and real estate. "I am honoured to join the board at such a pivotal and exciting time. I look forward to leveraging my experience to help Sharon AI shape its strategic goals and expand its impact in the coming years," sai

    3/3/26 7:30:00 AM ET
    $MSFT
    $NOK
    $PYPL
    Computer Software: Prepackaged Software
    Technology
    Radio And Television Broadcasting And Communications Equipment
    Diversified Commercial Services

    United Gives MileagePlus Credit Cardholders More Miles, Exclusive Flight Discounts

    MileagePlus members with a credit, debit or Chase co-branded card can soon earn up to twice as many miles for United flights as non-cardholders, get at least 10% off award tickets and access to exclusive Saver Award faresUnited now offers its most loyal members who have a United card some of the richest rewards among airline or travel credit card programsCHICAGO, Feb. 19, 2026 /PRNewswire/ -- United Airlines is giving travelers three new reasons to hold and use a United MileagePlus® credit or debit card: the ability to earn up to twice as many miles as non-cardholders, at least 10% off United award tickets and access to special inventory of its lowest-priced award seats.

    2/19/26 8:00:00 AM ET
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    Danaher To Acquire Masimo Corporation

    WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ:MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash. This represents a transaction multiple of approximately 18x estimated 2027 EBITDA, or 15x 2

    2/17/26 8:00:00 AM ET
    $DHR
    $MASI
    Industrial Machinery/Components
    Industrials
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care